XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Is this a fraud? We may be exited on way up , but

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Oct 15, 2021 11:39am

157 Views

Post# 34009973

RE:Is this a fraud? We may be exited on way up , but

It seems like a FRAUD,,,Nasdaq NR did nothing and ONLY 13MILLION SHARES for the ROBBERS at the INSTITUTIONS who are PLAYING, MANIPULATING our CEO ALLEN.

ROLLBACK 1st and then ALLEN is doing a CLAWBACK on us.